Aims Terminal differentiation of cardiac myocyte is associated with their permanent withdrawal from the cell cycle. In adult end-stage heart failure, significant numbers of myocytes express proliferating cell nuclear antigen yet fail to progress to cell division. Cyclin dependent kinase inhibitors are powerful inhibitors of the cell cycle and may play a direct role both in myocyte development and in preventing cell division in the adult.
Introduction
During early development, cardiac myocytes differentiate from pre-cardiac mesoderm, forming a pool of cells expressing a wide variety of markers of striated muscle. These cells retain the ability to divide, and during subsequent fetal life increased cardiac mass is largely the result of cell proliferation [1] . By early neonatal life, myocyte cell division has largely ceased and the subsequent increase in cardiac mass involves myocyte hypertrophy. Withdrawal of myocytes from the cell cycle is irreversible and the adult heart responds to trophic stimuli, such as pressure overload, by undergoing increased hypertrophy [2] , a process involving protein synthesis, expression of immediate early genes (c-fos, c-jun, egr-1 and hsp70) and activation of genes normally associated with cardiac development [3] [4] [5] [6] . Cardiac hypertrophy is the physiological response to pressure overload but becomes pathological when it exceeds normal limits, resulting in loss of contractile performance and ultimately in heart failure [7] . Our understanding of the factors which regulate the transition from hyperplastic to hypertrophic growth is incomplete, but the process is likely to involve key regulators of the cell cycle [8] . Principle negative regulators of cell cycle are the cyclin dependent kinase inhibitors, of which there are two families: the INKs and the CIP/KIPs (comprising p21, p27 and p57) [9] [10] [11] . These regulate the activity of the cyclin dependent kinases. The G 1 cyclin-dependent kinases 4 and 6 are predominantly responsible for phosphorylating the retinoblastoma protein and hence driving the cell cycle through G 1 . In its hypophosphorylated state retinoblastoma protein binds and inactivates the transcription factor E2F, which otherwise positively regulates the transcription of genes Revision submitted 3 July 1998, and accepted 12 July 1998.
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0195-668X/99/080604+08 $18.00/0essential for progression through the synthesis (S) phase [12] . Initially, G 1 is driven by cyclin D-cyclindependent kinase 4 and later by cyclin E-cyclindependent kinase 2. The expression and activities of these molecules have been shown to decrease dramatically during cardiac development in the rat [13] . The G 1 /S boundary is also regulated by proliferating cell nuclear antigen, which is required for DNA synthesis [14] . Once the START point in late G 1 is reached the cell loses its growth factor dependence and must divide. While the INK family of cyclin dependent kinase inhibitors are restricted to control of G 1 by virtue of inhibiting cyclindependent kinase 4 and 6 [15] , the CIP/KIPs inhibit all phases of the cycle. The N-terminus of p21 binds and inhibits cyclin-dependent kinases, and its C-terminus binds and inactivates proliferating cell nuclear antigen.
In spite of their importance in regulating the cell cycle, the expression of the CIP/KIP cyclin dependent kinase inhibitors has not been investigated in heart failure. Other cell cycle regulators show altered expression. For example, in normal adult myocardium, postmitotic myocytes do not express proliferating cell nuclear antigen but expression occurs in 50% of myocytes from both the left and right ventricles in end-stage failure [16] . Dilated cardiomyopathy in the dog is also associated with proliferating cell nuclear antigen up-regulation [17] . In spite of increased proliferating cell nuclear antigen expression, mitotic figures are extremely rare, even in end-stage failure [16] . There appears, therefore, to be an apparent block to cell division in the myocyte occurring distal to proliferating cell nuclear antigen expression. We hypothesized that altered expression of CIP/KIP cyclin dependent kinase inhibitors or retinoblastoma protein could contribute to this block. As heart failure and hypertrophy are associated with the re-expression of genes normally associated with fetal cardiac development, we have undertaken an investigation of the expression of CIP/KIP cyclin dependent kinase inhibitors and retinoblastoma protein during the development of acute and end-stage heart failure and compared it to that seen during cardiac development in both the human and rat.
Methods

Human and rat fetal heart samples
Human fetal and post-natal myocardium was obtained from elective terminations or at autopsy and stored in liquid nitrogen before use. Samples of late fetal (>20 weeks) and post-natal heart were of ventricular muscle only, earlier samples were predominantly ventricular although contamination with atrial muscle could not be excluded. Rat tissue was obtained from time-mated female Sprague dawley rats. Animals were killed, fetuses removed and hearts dissected with the aid of a microscope. Samples from fetuses aged >ED15 contained only ventricular tissue, while earlier samples were from whole heart. Two independent developmental series were prepared. In each case, for fetal and neonatal samples, eight hearts were pooled for each time point. For adult samples, transmural left ventricular free wall myocardium was pooled from three hearts. The first series was analysed once and the second twice.
Human heart failure samples
End-stage heart failure samples were obtained at the time of transplantation from patients with idiopathic dilated cardiomyopathy (n=5) or ischaemic cardiomyopathy (n=4). Tissue was frozen in liquid nitrogen and stored in liquid nitrogen until required. Acute heart failure samples were obtained from human brain-dead organ donors whose hearts were not used for transplantation because of ejection fractions <30% (assessed by transoesophageal echocardiography) and poor haemodynamic parameters (elevated left and right atrial pressures coupled with hypotension). All brain-dead organ donors show some degree of myocardial dysfunction; however, those with the severest form (as described above) were used in this study. Control 'normal' adult myocardium was obtained from three potential donors with normal ventricular function, but whose hearts were not used for donation because of triple vessel coronary artery disease. In all cases, myocardial samples were of transmural left ventricular free wall from an area without overt signs of fibrosis or obvious damage on visual inspection, or of hypertrophy as judged by transoesophageal echocardiography.
Western blot analysis
Total protein extracts were prepared by homogenising heart tissue in lysis buffer (1% SDS v/v, 1 m PMSF, 10 g . ml 1 aprotinin and 10 g . ml 1 leupeptin) and were stored at 20 C. The protein content of each sample was determined using the Pierce BCA kit. Samples (containing the same amount of total protein, 30 g . lane 1 ) were boiled with SDS loading buffer and then loaded onto 12·5% denaturing polyacrylamide gels for detection of p21, p27 and p57, or 5% polyacrylamide gels for detection of retinoblastoma protein. Gels were blotted onto nitrocellulose membrane (Hybond-C super), and blocked with Proto-block (National Diagnostics). Membranes were incubated with a monoclonal antibody raised against either p21 or p27 at a concentration of 1 g . ml 1 , a polyclonal antisera raised against p57 at 2 g . ml 1 (Oncogene Research Products, Cambridge, MA, U.S.A.) or a purified polyclonal antisera raised against retinoblastoma protein at a concentration of 0·1 g . ml 1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, U.S.A.). Membranes were washed thoroughly and incubated with appropriate secondary antibodies linked to horseradish peroxidase. Bands were detected using chemiluminessence and the
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ECL kit (Amersham Life Sciences, Amersham, U.K.). To ensure equal protein loading per lane, membranes were stripped, re-probed for sarcomeric actin at a dilution of 1/1000 (Sigma Chemical Company) or stained for total protein using amido black.
Bands were scanned using an IS 1000 image analysis system. The intensity of each band was assessed densitometrically and shown in the figures, along with representative Western blot results. Data are shown as % change in expression SE, and significance was assessed using Student's t-test.
Results
CIP/KIP cyclin dependent kinase inhibitor expression during cardiac development
The pattern of expression of p21, p27, and p57 was determined in fetal, neonatal and adult rat heart samples. The principal change in CIP/KIP cyclin dependent kinase inhibitor expression was a transition in the level of detectable p21 and p57. During early fetal stages (ED12-15), p21 was undetectable. By ED17, low but consistent amounts of p21 protein could be seen. Thereafter, levels increased throughout fetal life and reached a maximum in the adult (Fig. 1) . The pattern is consistent with a continuous, gradual rise in p21 throughout life with no evidence for a particular phase of increased expression or for a significant increase in neonatal life. p27 levels increased from day 12 to 15 and then remained significantly elevated throughout development. While some variation was seen between samples, this did not show statistical significance. p57 was readily detectable at ED12, markedly reduced by ED17 and was undetectable at all other stages. In human samples the overall pattern was essentially the same as that seen in rat: p21 was detectable during fetal development and its level of expression increased in post-natal life (Fig. 2) . p27 expression was increased by 25 weeks of fetal life but remained essentially constant thereafter. p57 decreased in expression with developmental age, although in contrast to the rat it remained detectable in the adult. Retinoblastoma protein levels also declined with increasing developmental age, and we were unable to detect evidence of a change in the phosphorylation status of the protein.
CIP/KIP cyclin dependent kinase inhibitor and retinoblastoma protein expression in acute and end-stage heart failure
In order to examine the expression of the CIP/KIP cyclin dependent kinase inhibitors and retinoblastoma protein in heart failure two groups of samples were collected. The first group (exhibiting acute failure; n=7) consisted of left ventricular myocardium from braindead organ donors with ejection fraction <30% and poor haemodynamic characteristics). The second group (n=9; ischaemic cardiomyopathy n=4, idiopathic dilated cardiomyopathy n=5) consisted of left ventricular myocardium from patients with end-stage heart failure obtained at the time of orthotopic transplantation. Each of the CIP/KIP cyclin dependent kinase inhibitors examined showed a significant difference in expression between normal and heart failure samples, both for the end-stage and the acute groups (Fig. 3) . p21 levels were reduced in both cases with a greater reduction in end-stage heart failure. Similarly, p27 levels were reduced in both groups, most prominently in the samples from patients with acute neurogenic failure. p57 expression was significantly elevated in both acute neurogenic, and to a greater extent, in the end-stage heart failure group. Retinoblastoma protein levels appeared reduced in both forms of heart failure but this was not significant in either case.
Discussion
We have examined the expression of the CIP/KIP cyclin dependent kinase inhibitors p21, p27 and p57 during cardiac development in both rat and man and in heart failure in man. The results show significant alterations in the abundance of these proteins during development, with the most marked change being an increase in p21 and a reciprocal decrease in p57 with developmental age. Our data further demonstrate that the levels of both p21 and p27 are significantly decreased in both acute and end-stage heart failure while p57 is significantly upregulated. Analysis of retinoblastoma protein levels in man showed a developmental decrease in expression but no alteration in abundance in heart failure. As cardiac myocytes occupy over 80% of the volume of ventricular wall [18] and probably contribute over 90% of protein in whole tissue extracts as used here, we propose that the pattern observed reflects the level of expression in these cells. Furthermore, we have confirmed that p21 and p27 are readily detectable in isolated myocytes in culture and that the level in cardiac non-myocytes is markedly lower (data not shown).
During fetal life, cardiac myocytes proliferate and differentiate into post-mitotic cells. These two processes occur together and the timing of cell cycle withdrawal occurs at different points in individual cells, such that some myocytes cease dividing during fetal life while others continue to proliferate into neonatal life [19, 20] . The increased expression of p21 observed during development in both rat and man is consistent with a direct role in cardiac myocyte cell cycle withdrawal. Moreover, the increasing expression of p21 correlates well with the previously observed reduction in thymidine incorporation during development [21] (as illustrated in Fig. 4 ). The rise in p21 expression described here from early stages of cardiac development in both the rat and human is in agreement with other recent published observations 
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in the rat [22, 23] . However, a recent report [24] has described a decrease in p21 expression occurring after day 10 in the neonatal rat heart. The reason for this discrepancy is not known and we have verified our results using two different antibodies and two independent series of rat heart samples.
The role that p57 may play in cardiac myocyte development is uncertain given its transient and early pattern of expression in the rat. These data are consistent with a role in regulation of some aspect of early myocyte development, for example early terminal differentiation of a minor population of myocytes. Interestingly, the hearts of p57 / knockout mice appear normal [25] , although other tissues have been noted to have increased levels of apoptosis [26] . Whether p57 is involved in regulating cell cycle withdrawal and/or apoptosis during early cardiac development requires further investigation. In the human, p57 expression is highest during early developmental stages but persists into adulthood, again suggesting a role in some other aspect of cardiac myocyte biology other than terminal differentiation.
p27 expression increased from day 12 in the rat and week 19 in the human fetus. Levels then remained essentially high and unchanged into adulthood. As with p57 this pattern of expression is difficult to reconcile with the timing of cardiac myocyte cell cycle exit. However, other studies have implicated p27 (or the p27 related molecule dacapo) in the regulation of cell number in both Drosophilla [27, 28] and mouse [29] [30] [31] . Hearts of p27 / animals are about 35% larger than wild type and contain significantly greater numbers of cells [29] [30] [31] . This effect appears to occur during fetal or early neonatal development as we are unable to detect bromodeoxyuridine incorporation (a marker of cell proliferation) in 15-day-old neonates in either p27 / animals or their wild type littermates, suggesting that terminal withdrawal has occurred by this time (P. B. J. Burton unpublished observations).
In the human series, retinoblastoma protein levels declined during fetal life, in agreement with the trend observed in the rat [32] . As with p21, this profile fits with the overall loss of proliferative potential.
The study reported here is the first to describe the expression of CIP/KIP cyclin dependent kinase inhibitors in acute and end-stage heart failure. It is widely accepted that heart failure is in many cases associated with a reversion to a fetal type pattern of gene expression as exemplified by the genes encoding ANF, 
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MLC2A, MHC and SERCA2 [33, 34] . Our data show that in both acute and end-stage heart failure, there is a significant change in cyclin dependent kinase inhibitor expression. Levels of p21 and p27 declined, while p57 levels increased, in line with an overall reversion to the fetal pattern of expression. Moreover, the level of expression seen in failure is similar to that during fetal life at a time when myocytes are actively dividing. In spite of this alteration in cyclin dependent kinase inhibitor expression and the elevated expression of proliferating cell nuclear antigen [16] , adult myocytes remain unable to divide. The level of retinoblastoma protein was not significantly altered in either acute or end-stage heart failure compared to normal adult myocardium. Additionally, its phosphorylation status, and hence activity, appeared to be unaltered. Similarly, pressure overload hypertrophy in the rat neither alters the level of retinoblast protein expression nor its phosphorylation status [32] , but it does appear to result in a significant reduction in the expression of p21 and p27 [35] . However, in this case the reduction in expression is transient. Whether the changes in cyclin dependent kinase inhibitor expression seen here occur late in the progression to end-stage heart failure is uncertain, in addition we do not know if levels return to normal once the acute heart failure seen in brain-dead patients is rectified. However, one possibility to explain the failure of cardiac myocytes to undergo cell division, in spite of the changes in cyclin dependent kinase inhibitor expression observed in heart failure and hypertrophy, may be an uncoupling of the action of cyclin dependent kinase inhibitors from the activation status of retinoblastoma protein. It is also possible that the elevated levels of p57 observed in heart failure counteract the reduced p21 and p27 levels, resulting in a net inhibition of cyclin-dependent kinase activity, or that the reduced cyclin/cyclin-dependent kinase levels seen in adult heart [13] are of insufficient quantity to phosphorylate retinoblastoma protein.
The decreased expression of p21 and p27 in acute and end-stage heart failure in man is similar to that observed in pressure overload hypertrophy in the rat. Direct comparison between these situations is complicated since in the rat the decrease in p21 and p27 expression is transitory. Whether progression to heart failure would be accompanied by reduced p21 and p27 levels in these animals remains to be determined. In man the temporal response of p21 and p27 during the progression to end-stage failure is likewise unknown and it may be that the alterations observed here occur only late in the natural history of the disease. Similarly, the acute heart failure samples examined from unused donors may mimic acute pressure and volume overload. Whether expression of p21 and p27 would return to normal levels if these organs had been successfully transplanted is unknown.
A further possibility is that cells stimulated to divide are driven towards apoptosis. Evidence for this comes from studies in which DNA synthesis induced in myocytes transfected with the E1A gene triggers apoptosis, rather than division [36] . Even where apoptosis is prevented by co-transfection with the E1B gene, cell division still fails to occur [37] . Apoptosis is observed in a significant number of myocytes in heart failure [38] and the potential link between altered cyclin dependent kinase inhibitor expression and apoptosis requires further investigation. 
